PMID- 31448702 OWN - NLM STAT- MEDLINE DCOM- 20211021 LR - 20211021 IS - 2295-3337 (Electronic) IS - 1784-3286 (Linking) VI - 76 IP - 1 DP - 2021 Feb TI - Interplay between metabolic and thyroid parameters in obese pubertal children. Does visceral adipose tissue make the first move? PG - 40-48 LID - 10.1080/17843286.2019.1660021 [doi] AB - Objectives: The mechanisms of obesity-associated thyroid dysfunction in children are incompletely deciphered. We aimed to evaluate whether visceral adipose tissue (VAT), insulin resistance (IR), inflammation, oxidative stress (OS) are involved in thyroid morpho-functional changes in pubertal obese children. Methods: We recruited 43 obese pubertal children without history of thyroid pathology. Metabolic and thyroid parameters (visceral fat thickness [VFT], waist/hip ratio [WHR], waist/height ratio [WHtR], insulin, glucose, liver parameters, thyroid stimulation hormone [TSH], free thyroxine [FT4], free triiodothyronine [FT3], thyroid and abdominal ultrasonography) were evaluated. Serum monocyte chemoattractant protein-1 (MCP-1) and malondialdehyde (MDA) levels were quantified as markers of inflammation and OS. Results: VFT correlated positively both with WHR (p= 0.034) and the presence of thyroid nodules (p= 0.036). WHR associated with TSH (p= 0.005), FT3/FT4 (p= 0.033) and was independently associated with FT3/FT4 increase (p< 0.001). HOMA-IR increased with visceral obesity (waist circumference, p= 0.001; WHR, p= 0.018; WHtR: p< 0.001), hepatic impairment (alanine aminotransferase, p= 0.019) and hepatic steatosis (HS; p= 0.013) and correlated positively with FT3/FT4 (p= 0.036). TSH was significantly higher in subjects with HS versus those without HS (p= 0.007) and logistic regression analysis identified TSH as a risk factor for HS (p= 0.014). MDA correlated positively with MCP-1 (p= 0.021). Conclusion: VAT and IR may be responsible for changes in thyroid parameters associated with obesity: elevated TSH, FT3/FT4 levels and increased prevalence of thyroid nodules. WHR was predictive of increased FT3/FT4. In obese children, there is an interdependent relationship between HS and thyroid function. FAU - Racataianu, Nicoleta AU - Racataianu N AD - Department of Endocrinology, Iuliu Hatieganu University of Medicine and Pharmacy , Cluj-Napoca, Romania. FAU - Leach, Nicoleta V AU - Leach NV AUID- ORCID: 0000-0003-0350-870X AD - 5th Department of Internal Medicine, Iuliu Hatieganu University of Medicine and Pharmacy , Cluj-Napoca, Romania. FAU - Bolboaca, Sorana D AU - Bolboaca SD AD - Department of Medical Informatics and Biostatistics, Iuliu Hatieganu University of Medicine and Pharmacy , Cluj-Napoca, Romania. FAU - Soran, Maria Loredana AU - Soran ML AD - National Institute for Research and Development of Isotopic and Molecular Technologies , Cluj-Napoca, Romania. FAU - Opris, Ocsana AU - Opris O AD - National Institute for Research and Development of Isotopic and Molecular Technologies , Cluj-Napoca, Romania. FAU - Dronca, Eleonora AU - Dronca E AUID- ORCID: 0000-0002-1829-3070 AD - Molecular Sciences Department, Iuliu Hatieganu University of Medicine and Pharmacy , Cluj-Napoca, Romania. FAU - Valea, Ana AU - Valea A AD - Department of Endocrinology, Iuliu Hatieganu University of Medicine and Pharmacy , Cluj-Napoca, Romania. FAU - Ghervan, Cristina AU - Ghervan C AUID- ORCID: 0000-0003-0016-0349 AD - Department of Endocrinology, Iuliu Hatieganu University of Medicine and Pharmacy , Cluj-Napoca, Romania. LA - eng PT - Journal Article PT - Observational Study DEP - 20190824 PL - England TA - Acta Clin Belg JT - Acta clinica Belgica JID - 0370306 RN - 0 (Blood Glucose) RN - 0 (Insulin) RN - 0 (Thyroid Hormones) SB - IM MH - Adolescent MH - Blood Glucose/analysis MH - Child MH - Cross-Sectional Studies MH - Fatty Liver MH - Female MH - Humans MH - Inflammation MH - Insulin/analysis MH - Insulin Resistance/*physiology MH - Intra-Abdominal Fat/*physiopathology MH - Male MH - *Pediatric Obesity/epidemiology/physiopathology MH - Thyroid Diseases MH - Thyroid Hormones/*blood OTO - NOTNLM OT - Visceral adiposity OT - insulin resistance OT - obesity OT - systemic inflammation OT - thyroid disorders EDAT- 2019/08/27 06:00 MHDA- 2023/02/25 06:00 CRDT- 2019/08/27 06:00 PHST- 2019/08/27 06:00 [pubmed] PHST- 2023/02/25 06:00 [medline] PHST- 2019/08/27 06:00 [entrez] AID - 10.1080/17843286.2019.1660021 [doi] PST - ppublish SO - Acta Clin Belg. 2021 Feb;76(1):40-48. doi: 10.1080/17843286.2019.1660021. Epub 2019 Aug 24.